RVMD Revolution Medicines Inc

Price (delayed)

$156.08

Market cap

$33.18B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$7.1

Enterprise value

$33.17B

?
Relative Growth: Rel. Growth: 0
Relative Strength: Rel. Strength: 96
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 2

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit high-value frontier targets in RAS-addicted cancers. The company possesses sophisticated structure-based drug discovery capabilities ...

Highlights
Revolution Medicines's net income has plunged by 97% YoY and by 21% from the previous quarter
The EPS has dropped by 77% year-on-year and by 19% since the previous quarter

Key stats

What are the main financial stats of RVMD

RVMD stock price

How has the Revolution Medicines stock price performed over time
Intraday
0.06%
1 week
0.94%
1 month
5.53%
1 year
286.53%
YTD
95.96%
QTD
60.49%

Financial performance

How have Revolution Medicines's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$1.39B
Net income
-$1.37B
Gross margin
N/A
Net margin
N/A
Revolution Medicines's net income has plunged by 97% YoY and by 21% from the previous quarter
RVMD's operating income has dropped by 76% year-on-year and by 17% since the previous quarter

Price vs fundamentals

How does RVMD's price correlate with its fundamentals

Growth

What is Revolution Medicines's growth rate over time

Valuation

What is Revolution Medicines stock price valuation
P/E
N/A
P/B
20.62
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has dropped by 77% year-on-year and by 19% since the previous quarter
The P/B is 161% higher than the last 4 quarters average of 7.9
The company's equity fell by 28% YoY and by 8% QoQ

Efficiency

How efficient is Revolution Medicines business performance
Revolution Medicines's return on equity has shrunk by 124% YoY and by 32% QoQ
RVMD's ROA has shrunk by 80% YoY and by 23% QoQ
RVMD's ROIC has dropped by 57% year-on-year and by 21% since the previous quarter

Dividends

What is RVMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RVMD.

Financial health

How did Revolution Medicines financials performed over time
RVMD's total assets is 199% greater than its total liabilities
Revolution Medicines's total liabilities has soared by 162% YoY and by 4.2% from the previous quarter
RVMD's quick ratio has dropped by 50% year-on-year and by 5% since the previous quarter
The debt is 71% less than the equity
The company's equity fell by 28% YoY and by 8% QoQ
The debt to equity has grown by 12% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.